Challenges and perspectives in the immunotherapy of Hodgkin lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Challenges and perspectives in the immunotherapy of Hodgkin lymphoma

Published:2017-11 Issue: Volume:85 Page:67-77
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Michot Jean-Marie^ORCID,Lazarovici Julien,Ghez David,Danu Alina,Fermé Christophe,Bigorgne Amélie,Ribrag Vincent,Marabelle Aurélien,Aspeslagh Sandrine

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference90 articles.

1. Treatment of Hodgkin lymphoma: a 50-Year perspective;Canellos;J Clin Oncol,2014

2. State of the art in the treatment of Hodgkin lymphoma;Borchmann;Nat Rev Clin Oncol,2012

3. Review of the cardiac long-term effects of therapy for Hodgkin lymphoma;Ng;Br J Haematol,2011

4. Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study;van der Kaaij;J Clin Oncol Off J Am Soc Clin Oncol,2012

5. Second cancer risk up to 40 Years after treatment for Hodgkin's lymphoma;Schaapveld;N Engl J Med,2015

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody blockade of the PSGL-1 immune checkpoint enhances T-cell responses to B-cell lymphoma;2024-03-11

2. Antibody targeting of surface P‐selectin glycoprotein ligand 1 leads to lymphoma apoptosis and tumorigenesis inhibition;Hematological Oncology;2024-02-28

3. Antibody targeting of surface PSGL-1 glycoprotein leads to lymphoma apoptosis and tumorigenesis inhibition;2024-01-22

4. Efficacy and safety of immune checkpoint inhibitors combined with anti-VEGF therapy in the treatment of unresectable or advanced liver cancer: a systematic review;Immunopharmacology and Immunotoxicology;2023-05-25

5. Lymphomas;Pediatric Surgery;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3